| L-METHYL-1-METHIONINE | L-METHYL-1-METHIONINE | |
| L-(-)METHAMIDOPHOS | L-(-)METHAMIDOPHOS | |
| L-METHIONYL-D-METHIONINE | L-METHIONYL-D-METHIONINE | |
| L-METHYLPHENIDATE | [(αS,2S)-α-フェニル-2α-ピペリジン酢酸]メチル | 29419-95-2 |
| L-Methyl-N-Acetyl-3-chloro alaninate | L-Methyl-N-Acetyl-3-chloro alaninate | |
| L-MethionineAminoAcid | L-MethionineAminoAcid | |
| l-Methoxyphenamine | l-Methoxyphenamine | 111138-72-8 |
| l-methylcysteine | l-methylcysteine | 95244-61-4 |
| L-Methionine | L-Methionine | 63-68-3 |
| L-Methionine-1-13C-methyl-D3 | L-Methionine-1-13C-methyl-D3 | |
| L-METHIONINE GAMMA-LYASE | L-メチオニンΓ-リアーゼ | 42616-25-1 |
| L-Met-3-(Iodoacetylamino)-L-Ala-OH | L-Met-3-(ヨードアセチルアミノ)-L-Ala-OH | |
| L-Met-L-Met-L-Arg-L-Asp-L-Ser-Gly-L-Cys-L-Phe-Gly-L-Arg-L-Arg-L-Ile-L-Asp-L-Arg-L-Ile-Gly-L-Ser-L-Leu-L-Ser-Gly-L-Met-Gly-L-Cys-L-Asn-Gly-L-Ser-L-Arg-L-Lys-L-Asn-OH | 心房性ナトリウム利尿因子【トリ還元型】 | |
| L-Met-L-Nva-N3-[(E)-3-(Methoxycarbonyl)propenoyl]-L-A2pr-OH | L-Met-L-Nva-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-OH | |
| L-Met-L-Leu-Gly-OH | N-(N-L-メチオニル-L-ロイシル)グリシン | 14486-11-4 |
| L-Met-L-Phe-L-Val-NH2 | ムラサキイガイ抑制ペプチド(4-6) | |
| L-Met-L-Ala-N3-[(E)-3-(Methoxycarbonyl)propenoyl]-L-A2pr-OH | L-Met-L-Ala-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-OH | |
| L-Met-L-Lys-OH | Nα-L-メチオニル-L-リシン | |
| L-Met-L-Asn-L-Val-L-Phe-L-Ala-OBzl | L-Met-L-Asn-L-Val-L-Phe-L-Ala-OBzl | |
| L-Met-L-Met-N3-[(E)-3-(Methoxycarbonyl)propenoyl]-L-A2pr-OH | L-Met-L-Met-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-OH | |
| L-Met-L-Met-L-Met-L-Met-N3-[(E)-3-(Methoxycarbonyl)propenoyl]-L-A2pr-OH | L-Met-L-Met-L-Met-L-Met-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-OH | |
| L-Met-L-Nva-3-(Iodoacetylamino)-L-Ala-OH | L-Met-L-Nva-3-(ヨードアセチルアミノ)-L-Ala-OH | |
| L-Met-L-Met-L-Met-N3-[(E)-3-(Methoxycarbonyl)propenoyl]-L-A2pr-OH | L-Met-L-Met-L-Met-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-OH | |
| L-Met-NNap | N-(2-ナフチル)-L-メチオニンアミド | |
| L-Met-N3-[(E)-3-(Methoxycarbonyl)propenoyl]-L-A2pr-N3-[(E)-3-(methoxycarbonyl)propenoyl]-L-A2pr-OH | L-Met-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-OH | |
| L-Met-N3-[(E)-3-(Methoxycarbonyl)propenoyl]-L-A2pr-L-Met-OH | L-Met-N3-[(E)-3-(メトキシカルボニル)プロペノイル]-L-A2pr-L-Met-OH | |
| L-MET-TYR NH2 HCL | L-MET-TYR NH2 HCL | |
| LM1 ganglioside | LM1 ganglioside | |
| l-Mexiletine | l-Mexiletine | 94991-73-8 |
| LLOYD AND MCCOWN'S WOODY PLANT BASAL SALT MIXTURE | MCCOWN木本基礎塩類混合粉末 | |
| LLOYD REAGENT | LLOYD REAGENT | |
| LMFP protocol | LMFP protocol | |
| LMF protocol | LMF protocol | |
| LL5 protein | LL5 protein | |
| LLREP3 protein | LLREP3 protein | 130122-51-9 |
| LL - 37, reverse sequence | LL - 37, reverse sequence | |
| LL-S-491-beta | LL-S-491-beta | |
| LLT1 | LLT1 | |
| L-Mimosine (leucenol) | N-(4-クロロフェニル)-1,3,5-トリアジン-2,4-ジアミン | 500-42-5 |
| L-MIMOSINE | [αS,(-)]-α-アミノ-3-ヒドロキシ-4-オキソ-1(4H)-ピリジンプロピオン酸 | 500-44-7 |
| LMINOSTILBENE (BROMINE FREE) | LMINOSTILBENE (BROMINE FREE) | |
| LMINODIACETIC ACID IDA | LMINODIACETIC ACID IDA | |
| L-LSOGLUTAMINE | L-LSOGLUTAMINE | |
| Lmipenen | Lmipenen | |
| 1$l^{4},3,5$l^{4},7-tetrathia-2,4,6,8-tetrazacycloocta-1,4,5,8-tetraene | 1$l^{4},3,5$l^{4},7-tetrathia-2,4,6,8-tetrazacycloocta-1,4,5,8-tetraene | 28950-34-7 |
| LMK-235 | LMK235 | 1418033-25-6 |
| lL-Thyroxinesodiumsaltpentahydrate | lL-Thyroxinesodiumsaltpentahydrate | |
| LNA-A diol | LNA-A diol | |
| L23 mitochondrial-related protein | L23 mitochondrial-related protein | |
| L-NAA HCL | L-NAA HCL | 1031799-40-2 |
| L-(NA-CARBOBENZOXY)THREONINEAMIDE | L-(NA-CARBOBENZOXY)THREONINEAMIDE | |
| L-N-Acetyl--chloroalanine, Methyl Ester | L-N-Acetyl--chloroalanine, Methyl Ester | |
| L-N-ACETYL-B-CHLOROALANINE, METHYL ESTER | L-N-ACETYL-B-CHLOROALANINE, METHYL ESTER | |
| L-N-ACETYL-(M-BIS-HYDROXYETHYLAMINO)-PHENYLALANINE METHYL ESTER, [3H]- | L-N-ACETYL-(M-BIS-HYDROXYETHYLAMINO)-PHENYLALANINE METHYL ESTER, [3H]- | |
| L-LUCIFERINFREEACID99 | L-LUCIFERINFREEACID99% | |
| L-Luciferin free acid 99 | L-Luciferin free acid 99% | |
| L-LUCIFERIN | L-LUCIFERIN | 34500-31-7 |
| L-NAFADOTRIDE | L-NAFADOTRIDE | 173429-65-7 |
| LNA-G diol | LNA-G diol | |
| L-N-(a-Methylbenzyl)linoleamide | L-N-(a-Methylbenzyl)linoleamide | 20917-61-7 |
| L-NAME | L-NAME | |
| L(-)-N-ALPHA-BOC-AMINO-EPSILON-CAPROLATAM | L(-)-N-ALPHA-BOC-AMINO-EPSILON-CAPROLATAM | |
| L(-)-N-ALPHA-TERT-BUTOXYCARBONYLAMINO-EPSILON-CAPROLATAM | L(-)-N-ALPHA-TERT-BUTOXYCARBONYLAMINO-EPSILON-CAPROLATAM | |
| llungianin B | llungianin B | |
| llungianin A | llungianin A | |
| (L)-N-Benzyloxycarbonyl--oxo-tryptophaneamide | (L)-N-Benzyloxycarbonyl--oxo-tryptophaneamide | 255371-72-3 |
| L-N-BENZYL-A-METHYLBENZYLAMINE | L-N-BENZYL-A-METHYLBENZYLAMINE | |
| (L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE | (L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE | 128018-17-7 |
| L-(-)-N-BENZYLOXY CARBONYL-A-HYDROXY-R-AMINO BUTYLIC ACID | L-(-)-N-BENZYLOXY CARBONYL-A-HYDROXY-R-AMINO BUTYLIC ACID | |
| L-N-benzyl-alpha-methylbenzylamine | L-N-benzyl-alpha-methylbenzylamine | |
| L-N-[1-BENZYL-2-(1-METHYL-1H-INDOL-3-YL)-2-OXOETHYL]-2,2,2-TRIFLUOROACETAMIDE | L-N-[1-BENZYL-2-(1-METHYL-1H-INDOL-3-YL)-2-OXOETHYL]-2,2,2-TRIFLUOROACETAMIDE | |
| (L)-N-(BENZYLOXYCARBONYL)PIPECOLIC ACID | (2S)-1-(ベンジルオキシカルボニル)ピペリジン-2α-カルボン酸 | 28697-11-2 |
| L-N-[1-BENZYL-2-OXO-2-(1H-PYRROL-2-YL)-ETHYL]-2,2,2-TRIFLUOROACETAMIDE | L-N-[1-BENZYL-2-OXO-2-(1H-PYRROL-2-YL)-ETHYL]-2,2,2-TRIFLUOROACETAMIDE | |
| L-(-)-N-BENZOXYLCARBONYL-ALPHA-HYDROXY-GAMMA-AMINO BUTYRIC ACID AMIKACIN | L-(-)-N-BENZOXYLCARBONYL-ALPHA-HYDROXY-GAMMA-AMINO BUTYRIC ACID AMIKACIN | |
| (L)-N-BENZYLOXYCARBONYL-B-OXO-TRYPTOPHANEAMIDE | (L)-N-BENZYLOXYCARBONYL-B-OXO-TRYPTOPHANEAMIDE | |
| L-N-[1-BENZYL-2-(1H-INDOL-3-YL)-2-OXOETHYL]-2,2,2-TRIFLUOROACETAMIDE | L-N-[1-BENZYL-2-(1H-INDOL-3-YL)-2-OXOETHYL]-2,2,2-TRIFLUOROACETAMIDE | |
| L-N-[1-BENZYL-2-(1-METHYL-1H-PYRROL-2-YL)-2-OXOETHYL]-2,2,2-TRIFLUOROACETAMIDE | L-N-[1-BENZYL-2-(1-METHYL-1H-PYRROL-2-YL)-2-OXOETHYL]-2,2,2-TRIFLUOROACETAMIDE | |
| L-1-Naphthylalanine | (S)-2-アミノ-3-(1-ナフチル)プロピオン酸 | 55516-54-6 |
| L-Naproxen | L-Naproxen | |
| L-Nateglinide | L-ナテグリニド | 105816-05-5 |
| L-NASPA | L-NASPA | 155915-46-1 |
| L-NASPA | N-パルミトイルセリンリン酸 | |
| L1 NCAM Monoclonal Antibody
| L1 NCAM Monoclonal Antibody
| |
| LNCAPFGC 10 CELL LYSATE | LNCAPFGC 10 CELL LYSATE | |
| LNCAP CLONE FGC CELL LINE (HUMAN) | LNCAP CLONE FGC CELL LINE (HUMAN) | |
| L-N-CBZ-3-PYRAZOL-1-YL-ALANINE | L-N-CBZ-3-PYRAZOL-1-YL-ALANINE | 20945-53-3 |
| L-N-Cbz-3-N-Boc-Amino-alanine | Z-3-(tert-ブトキシカルボニルアミノ)L-Ala-OH | 16947-84-5 |
| L-(4''-N-Cbz-piperidio)proline | L-(4''-N-Cbz-piperidio)proline | |
| L(+)-N-CBZ-ORNITHINE HYDROCHLORIDE
| L(+)-N-CBZ-ORNITHINE HYDROCHLORIDE
| 92455-59-9 |
| L-N-Boc-6-chlorotryptophan | L-N-BOC-6-クロロトリプトファン | 1234875-52-5 |
| L-N-[(4'-BOC)PIPERIDINO]PROLINE | 1-[1-(TERT-ブチルトキシカルボニル)-4-ピペリジニル]-L-プロリン | 221352-39-2 |
| LN-1, CD75, Sialoprotein (Cell Surface), Clone: LN-1, Mab anti-, suitable frozen/paraffin (protease pretreat)
| LN-1, CD75, Sialoprotein (Cell Surface), Clone: LN-1, Mab anti-, suitable frozen/paraffin (protease pretreat)
| |
| (l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride | (l)-m-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride | 2611-33-8 |
| LND 796 | (14β)-14-アミノ-3β-[(6-デオキシ-α-L-マンノピラノシル)オキシ]-5β-アンドロスタン-17β-カルボン酸メチル | 118549-42-1 |
| LND 623 | [(20R)-14β-アミノ-20-ヒドロキシ-5β-プレグナン-3β-イル]6-デオキシ-α-L-マンノピラノシド | 90520-42-6 |
| L-N-BUTYLSULFONYL-P-HYDROXYPHENYLALANINE | L-N-ブチルスルホニル-P-ヒドロキシフェニルアラニン | 149490-60-8 |
| L-N-(2,6-DIMETHYLPHENYL)-2-PIPERIDINE CARBOXAMIDE | L-N-(2,6-DIMETHYLPHENYL)-2-PIPERIDINE CARBOXAMIDE | |
| L-N-(2,6-dimethylphenl）-2-piperidine carboxamide | L-N-(2,6-dimethylphenl）-2-piperidine carboxamide | |
| LMO4 (full length)
| LMO4 (full length)
| |
| LNF 209 | LNF 209 | 144979-06-6 |